当前位置: 首页 > 期刊 > 《中国现代医生》 > 2017年第13期
编号:13053160
前列地尔合并肾康片对2型糖尿病肾病患者血清TNF—α、IL—6及IL—8水平的影响(4)
http://www.100md.com 2017年5月5日 中国现代医生 2017年第13期
     [14]Jan Wysocki,Laura Garcia-Halpin,Minghao Ye,et al.Regulation of urinary ACE2 in diabetic mice[J].AJP: Renal Physiology,2013,305(4):F600-F611.

    [15]Alva K,Aithala P,Rakesh Rai,et al.Clinical and microbiological profile of diabetic foot in patients admitted at a tertiary care center in Mangalore[J].Muller Journal of Medical Sciences and Research, 2013,4(1):3-7.

    [16]Currie G,Delles C.Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy[J].Current diabetes reports,2016,16(11):104.

    [17]Radovan Hojs,Robert Ekart,Sebastjan Bevc, et al.Biomarkers of Renal Disease and Progression in Patients with Diabetes[J].JCM,2015,4(5):1010-1024.

    [18]HF Gu,X Zheng,Abu Seman N,et al.Impact of the hypoxia-inducible factor-1 α(HIF1A) Pro582Ser polymorphism on diabetes nephropathy[J].Diabetes Care,2013,36(2):415-421.

    [19]Dilpesh Jain,Rahul Somani. Silibinin,a bioactive flavanone,prevents the progression of early diabetic nephropathy in experimental type-2 diabetic rats[J].International Journal of Green Pharmacy,2015, 9(2):118-124.

    [20]Sarita Bajaj,Raj Singh,N Dwivedi,et al.Vitamin D levels and microvascular complications in type 2 diabetes[J].Indian Journal of Endocrinology and Metabolism,2014,18(4):537-541.

    (收稿日期:2017-02-24), 百拇医药(邱冬豪 赵宁 王鸣)
上一页1 2 3 4